Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
J Pediatr Hematol Oncol ; 39(5): 370-375, 2017 07.
Article in English | MEDLINE | ID: mdl-28538500

ABSTRACT

The prevalence of obesity and related comorbidities in survivors of childhood acute lymphoblastic leukemia (ALL) is well established and ranges anywhere from 29% to 69% depending on the study. We sought to explore the awareness of parents of survivors of childhood ALL regarding the increased risk of obesity and their perceptions regarding the overall health of their child. One hundred twenty-one parents of 99 survivors of pediatric ALL completed surveys regarding perceptions of obesity risk in survivors. Eighty percent of parents of overweight and obese survivors correctly identified their child as "a little overweight" or "overweight." Few parents recalled discussing weight gain (21%) or obesity risk (36%) with their practitioner. Parents that did recall having these discussions and/or reported a decreased level of posttherapy activity in their child were more likely to be concerned about their child's weight status. Improved awareness and education regarding the risk of obesity and associated comorbid conditions may provide an avenue for future prevention of obesity in survivors of pediatric ALL. Discussion and education regarding a healthy lifestyle, including proper diet and exercise, should be incorporated early in routine patient visits.


Subject(s)
Family Relations , Obesity , Precursor Cell Lymphoblastic Leukemia-Lymphoma/complications , Adolescent , Child , Child, Preschool , Comorbidity , Humans , Infant , Parents , Perception , Risk , Surveys and Questionnaires , Survivors
2.
Echocardiography ; 34(2): 250-256, 2017 Feb.
Article in English | MEDLINE | ID: mdl-27996161

ABSTRACT

PURPOSE: To evaluate the feasibility and correlation of 3D echocardiography (echo) and cardiac biomarkers with cardiac MRI, in surveillance of cardiac function for cancer survivors. METHODS: Subjects ≥10 years of age who have survived >2 years after completion of cancer treatment from a single center were enrolled. Cardiac MRI and 3D echo images were obtained on the same day when routine echo was obtained. On the same day, along with annual routine blood test, cardiac biomarkers N-terminal pro-B-type natriuretic peptide levels (NT-proBNP) and troponin-I levels were also measured. RESULTS: Cardiac MRI was feasible in all 50 subjects. Three-dimensional echo and 2D echo images were of poor quality in four subjects. With a median duration of remission of 10 years, there were four subjects with mild LV dysfunction (cardiac MRI LV EF of<53%). None had MRI EF <50%, and nine subjects had LVEF <55%. M-mode echo overestimated EF more than 2D and 3D echo. Two-dimensional and 3D echo methods had much tighter limits of agreement for LV EF. For measurement of LVEF, 3D echo had a lower % error than 2D echo or M-mode echo. One subject had an abnormal troponin-I level and another one had an elevated NT-proBNP. CONCLUSIONS: Three-dimensional echo can be performed in most adolescent cancer survivors, and it correlates well with MRI. Further large-scale research is required in assessing utility of cardiac biomarkers in pediatric cancer survivors.


Subject(s)
Echocardiography, Three-Dimensional/methods , Heart/diagnostic imaging , Magnetic Resonance Imaging/methods , Neoplasms/blood , Adolescent , Biomarkers/blood , Child , Child, Preschool , Feasibility Studies , Heart/physiopathology , Humans , Infant , Male , Natriuretic Peptide, Brain/blood , Peptide Fragments/blood , Survivors , Troponin I/blood
3.
J Pediatr Nurs ; 30(5): e147-55, 2015.
Article in English | MEDLINE | ID: mdl-26202467

ABSTRACT

With a 5 year survival rate of approximately 80%, there is an increasing number of childhood cancer survivors in the United States. Childhood cancer survivors are at an increased risk for physical and psychosocial health problems many years after treatment. Long-term follow-up care should include education, development of individualized follow up plans and screening for health problems in accordance with the Children's Oncology Group survivor guidelines. Due to survivor, provider and healthcare system related barriers, adult survivors of childhood cancer (ASCC) infrequently are receiving care in accordance to these guidelines. In this paper we describe the stepwise process and collaboration between a children's hospital and an adult academic medical center that was implemented to develop the Survivorship Transition Clinic and address the needs of ASCC in our region. In the clinic model that we designed ASCC follow-up with a primary care physician in the adult setting who is knowledgeable about late effects of childhood cancer treatment and are provided transition support and education by a transition nurse navigator.


Subject(s)
Ambulatory Care Facilities/organization & administration , Delivery of Health Care/organization & administration , Health Plan Implementation/organization & administration , Neoplasms/therapy , Adult , Age Factors , Child , Continuity of Patient Care/organization & administration , Female , Humans , Male , Needs Assessment , Neoplasms/diagnosis , Pediatrics , Program Development , Program Evaluation , Survivors , United States
4.
Oncol Nurs Forum ; 40(3): 254-62, 2013 May 01.
Article in English | MEDLINE | ID: mdl-23615138

ABSTRACT

PURPOSE/OBJECTIVES: To report functional (physical and cognitive) late effects, experiences, and information needs of adult survivors of childhood cancer. DESIGN: Descriptive, mixed methods survey. SETTING: Two pediatric oncology programs in the Midwest. SAMPLE: Convenience sample of 272 young adult survivors. METHODS: Voluntary survey completion by young adult survivors regarding late effects, experiences, and educational needs to develop appropriate comprehensive care programs for care provision before, during, and after transition to adult care. Survey domains were identified from existing survivorship literature and focused on all aspects of survivorship; however, this article focuses on results specific to the functional domain. MAIN RESEARCH VARIABLES: Functional late effects, experiences, information needs, age, gender, and treatment intensity of young adult survivors of childhood cancer. FINDINGS: Response rate was 48%. Functional late effects, perceptions, and information needs all correlated with intensity of treatment (those survivors most heavily treated experienced the most symptoms). Survivors wanted more information about late effects and how to deal with them. Women wanted more information about fertility-related topics, and participants who received more intense treatment generally wanted more information. Brain tumor survivors perceived greater cognitive difficulties, cognitive late effects, fatigue, and financial difficulties. CONCLUSIONS: Survivors experience myriad physical late effects and require ongoing access to information as needs change over time. IMPLICATIONS FOR NURSING: Identifying new and innovative ways to reach survivors and better meet needs is important for care, research, and program development. KNOWLEDGE TRANSLATION: The findings of the research underscore the importance of continuous learning opportunities for adult survivors of childhood cancer. The findings also highlight the need for healthcare teams to better understand the current and long-term needs of this population. In addition to traditional communication approaches, technologies such as social media and telemedicine can provide innovative ways to deliver patient-centered care.


Subject(s)
Needs Assessment , Neoplasms/nursing , Neoplasms/psychology , Oncology Nursing/methods , Patient Education as Topic , Survivors/psychology , Adult , Child , Data Collection , Female , Health Status , Humans , Male , Middle Aged
5.
Curr Hematol Malig Rep ; 6(3): 195-205, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21695425

ABSTRACT

As survival rates for children treated for childhood cancers become significantly better, the focus is increasingly on determining the late effects of treatments and the best ways to monitor for them and prevent their occurrence. This review focuses on recent literature discussing the late effects of treatment in patients treated for acute myeloid leukemia and acute lymphoblastic leukemia during childhood. The late effects of therapy for childhood leukemia include secondary malignancy, cardiotoxicity, obesity, endocrine abnormalities, reproductive changes, neurocognitive deficits, and psychosocial effects. As clinicians have become more aware of the late effects of therapy, treatment regimens have been changed to decrease late effects, but patients still require long-term follow-up for their prevention and treatment.


Subject(s)
Leukemia, Myeloid, Acute/drug therapy , Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Antineoplastic Agents/adverse effects , Antineoplastic Agents/pharmacology , Antineoplastic Agents/therapeutic use , Central Nervous System Neoplasms/secondary , Child , Endocrine System Diseases/chemically induced , Endocrine System Diseases/etiology , Fertility/drug effects , Growth Disorders/chemically induced , Growth Disorders/etiology , Heart Diseases/chemically induced , Heart Diseases/etiology , Humans , Leukemia, Myeloid, Acute/pathology , Obesity/chemically induced , Obesity/etiology , Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology , Stress, Psychological
SELECTION OF CITATIONS
SEARCH DETAIL
...